Pasquale Sansone is a portfolio manager within the healthcare franchise at Candriam, with a specific focus on oncology directed research and investments.
Prior to joining Candriam, Pasquale served as an Oncology Investment Analyst at J. Goldman & Co and previously at Alera Partners, focusing on oncology investments and life sciences opportunities.
He graduated from the University of Bologna and Memorial Sloan-Kettering Cancer Center, US. Prior to his career in finance, Pasquale had spent 14 years as academic cancer researcher in the US.
Discover the latest articles by Pasquale Sansone
Pasquale Sansone, Actions, Healthcare
Il y a dix ans, l’idée de dépister un cancer à partir d’un échantillon sanguin, de cartographier le profil génétique d’une tumeur ou de concevoir un traitement personnalisé à l’aide de l’intelligence artificielle semblait relever de la science-fiction. Aujourd’hui, ces avancées sont en train d’être intégrées à la pratique clinique.